Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1760486443
Since 2005
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
49 Nesconset Hwy
Port Jefferson Station, NY, 11776
Phone (631) 751-0000
Groups this clinician bills Medicare through
Medicare paid, 2024
$2.4M
172,354 services
Medicare patients, 2024
1,917
Average age 75
Drug cost, 2024
$8.8M
2,554 prescriptions
Company payments, 2025
$41.48
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Regina L Jablonski was code J1439 (injection, ferric carboxymaltose, 1 mg), 46,500 times for 50 patients. In total Regina L Jablonski billed 172,354 services in 280 codes, and Medicare paid $2.4M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-01-17.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 46,500 | 50 | $0.88 | $41K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 18,900 | 28 | $2.31 | $44K |
| J1756 Injection, iron sucrose, 1 mg | Office | 10,600 | 34 | $0.18 | $1,900 |
| J9271 Injection, pembrolizumab, 1 mg | Office | 8,400 | 17 | $44.46 | $373K |
| J0897 Injection, denosumab, 1 mg | Office | 6,180 | 53 | $20.25 | $125K |
| 85025 Blood Count | Office | 3,550 | 1,405 | $7.58 | $27K |
| 36415 Venipuncture Blood Collection | Office | 3,509 | 1,348 | $8.62 | $30K |
| 88185 Surgical Pathology Examination | Office | 3,123 | 130 | $21.95 | $69K |
| 80053 Clinical Chemistry | Office | 2,973 | 1,302 | $10.29 | $31K |
| 84100 Clinical Chemistry | Office | 2,606 | 1,130 | $4.62 | $12K |
| 83735 Clinical Chemistry | Office | 2,570 | 1,095 | $6.53 | $17K |
| 84550 Clinical Chemistry | Office | 2,522 | 1,074 | $4.41 | $11K |
| 83615 Clinical Chemistry | Office | 2,506 | 1,050 | $5.88 | $15K |
| 82784 Immunoassay | Office | 2,376 | 452 | $9.01 | $21K |
| 99214 Office E&M - Established | Office | 2,179 | 908 | $107.93 | $235K |
By year: 2022 $4.6M for 295,026 services; 2023 $4.7M for 311,727 services; 2024 $2.4M for 172,354 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 3,550 | 1,405 | $7.58 | $27K |
| 36415 Venipuncture Blood Collection | 3,509 | 1,348 | $8.62 | $30K |
| 88185 Surgical Pathology Examination | 3,123 | 130 | $21.95 | $69K |
| 80053 Clinical Chemistry | 2,973 | 1,302 | $10.29 | $31K |
| 84100 Clinical Chemistry | 2,606 | 1,130 | $4.62 | $12K |
| 83735 Clinical Chemistry | 2,570 | 1,095 | $6.53 | $17K |
| 84550 Clinical Chemistry | 2,522 | 1,074 | $4.41 | $11K |
| 83615 Clinical Chemistry | 2,506 | 1,050 | $5.88 | $15K |
| 82784 Immunoassay | 2,376 | 452 | $9.01 | $21K |
| 82728 Clinical Chemistry | 1,928 | 914 | $13.28 | $26K |
Medicare prescription drug claims, 2024
In 2024, the drug Regina L Jablonski prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 201 prescriptions and refills. In total Regina L Jablonski wrote 2,554 Medicare prescriptions that cost $8.8M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 201 | 201 | 59 | $730K |
| Eliquis Apixaban | 103 | 185 | 36 | $105K |
| Allopurinol Generic | 75 | 159 | 25 | $1,082 |
| Exemestane Generic | 72 | 160 | 18 | $16K |
| Hydroxyurea Generic | 69 | 137 | 17 | $1,546 |
| Xgeva Denosumab | 63 | 65 | 13 | $195K |
| Procrit Epoetin Alfa | 59 | 59 | 11 | $186K |
| Ibrance Palbociclib | 53 | 53 | Under 11 | $815K |
| Fulvestrant Generic | 53 | 53 | Under 11 | $69K |
| Prednisone Generic | 51 | 67 | 20 | $262 |
| Xtandi Enzalutamide | 50 | 50 | Under 11 | $659K |
| Akynzeo Fosnetupitant/Palonosetron | 46 | 46 | Under 11 | $55K |
| Letrozole Generic | 44 | 94 | 15 | $740 |
| Xarelto Rivaroxaban | 44 | 86 | 14 | $48K |
| Acyclovir Generic | 38 | 94 | 13 | $800 |
Brand drugs: - claims; generic drugs: 1,333 claims; opioid claims: 32.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Regina L Jablonski $41.48 ($41.48 in general payments such as food, travel and fees) from 1 company. The largest payer was Genzyme Corporation with $41.48.
| Company | Payments | Amount |
|---|---|---|
| Genzyme Corporation SNY | 1 | $41.48 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.